MarketPeel
Insider Trading Intelligence
SG

Stephen C. Glover

PDSB
DIRECTOR · PDS BIOTECHNOLOGY CORP · CIK 0001304406
FILING MIX · LIFETIME100%/0%
BUYS
12
SELLS
0
TOTAL VALUE
$124.9K
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
150,876
AVG SELL PX
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Stephen C. Glover, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%-7.52%-3.07%-4.45%-4.45%
14d2+0.00%-7.52%-5.28%-2.24%-2.24%
30d2+0.00%-10.53%-5.57%-4.95%-4.95%
60d2+0.00%-5.26%-6.43%+1.17%+1.17%
90d2+100.00%+5.26%-0.40%+5.66%+5.66%
180d2+0.00%-3.76%+9.15%-12.91%-12.91%
1y2+0.00%-49.25%+15.80%-65.05%-65.05%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PDSB · 54,876 shares · as of Jan 12, 2026
019,71339,42659,13878,851202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 0 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ONCY
ONCOLYTICS BIOTECH INC
PURCHASEGRANT
Stock grant
96,00096,000Jun 1, 2026Jun 3, 2026View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
54,87654,876Jan 12, 2026Mar 3, 2026View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
22,70022,700Jun 11, 2025Jun 11, 2025View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
15,06115,061Feb 28, 2025Mar 3, 2025View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
15,061$1.66$25.0K78,851Feb 28, 2025Mar 3, 2025View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,0009,000Jun 24, 2024Jun 25, 2024View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,0009,000Jul 14, 2023Jul 17, 2023View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,0009,000Jun 28, 2022Jun 29, 2022View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,0009,000Jun 17, 2021Jun 17, 2021View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
5,882$8.50$50.0K63,790Jun 15, 2021Jun 17, 2021View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,0009,000Jun 23, 2020Jun 25, 2020View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
38,400$1.30$49.9K57,908Feb 14, 2020Feb 19, 2020View →
Other insiders · PDSB
Loading peer insiders…
About this filer
CIK 0001304406
ROLE
Director
PRIMARY
PDSB
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001304406DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback